Rare Pediatric Disease PRV Likely to Be Extended via Latest CR

Rare Pediatric Disease PRV Likely to Be Extended via Latest CR

Published On: 09/23/2024Tags: Biopharma, Cell and Gene Therapy, Drug Reform/Pricing, Health Insurance, Medical Devices, Oncology